Pharmaceutical Quality/Manufacturing Standards (CGMP)
Similar Posts
Early Alert: Automated Impella Controller Purge Retainer Fixation Issue from Abiomed
FDA is announcing an Early Alert for Abiomed’s Automated Impella Controller due to Purge Pressure IssuesPatient-Focused Drug Development
The OCE PFDD program fosters collaboration between FDA centers and external stakeholders involved in patient outcomes research in cancer populations.Bioresearch Monitoring Information System (BMIS)
Bioresearch Monitoring Information System (BMIS) background page with download file.Non-Compliance Letters under 505B(d)(1) of the Federal Food, Drug, and Cosmetic Act
Section 505B(d)(1) requires FDA to send a PREA Non-Compliance letter to sponsors who have failed to submit their pediatric assessments required under PREA by the final due date, have failed to seek or obtain a deferral or deferral extension.Inotiv Inc. – 10/24/2025
Inotiv Inc. – 10/24/2025. Country: United States. Record Type: 483Medispray Laboratories Private Limited – 01/20/2025
Medispray Laboratories Private Limited – 01/20/2025. Country: India. Record Type: 483
